Back
4D Molecular Therapeutics Inc (FDMT)
BiotechnologyFDMT · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$12.92
−5.49%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-2.42
ROE
-34.9%
Gross margin
-145.7%
Debt/Equity
4.54x
Revenue growth
21664.3%
4D Molecular Therapeutics Inc — company intelligence
Earnings surprises
Q2 2026$-1.04 vs $-1.04 est-0.3%
Q1 2026$-1.01 vs $-1.01 est+0.2%
Q4 2025$0.43 vs $-0.78 est+155.3%
Q3 2025$-1.01 vs $-1.00 est-1.2%
Analyst consensus · 18 analysts
15 Buy3 Hold0 Sell
Updated Oct 5, 2026
Insider activity · 90 days
0 buys2 sellsnet -39,257 shares
Kirn DavidSell 26,842 · Aug 4, 2026
Kirn DavidSell 12,415 · Aug 3, 2026
Recent SEC filings
4 — Insider transaction reportSep 22, 2026
4 — Insider transaction reportSep 16, 2026
4 — Insider transaction reportSep 3, 2026
Latest news
Chardan Capital Maintains Buy on 4D Molecular Therapeutics, Lowers Price Target to $25 — Benzinga · 4d ago
4DMT to Host Investor Day on October 21, 2026 — Yahoo · 5d ago
This is the top biotech stock pick from B Riley Securities — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.